1. Chinese Herbal Medicine on Cardiovascular Diseases and the Mechanisms of Action
   Cuiqing Liu et al, 2016, Front. Pharmacol. CrossRef
2. Natural Products to Counteract the Epidemic of Cardiovascular and Metabolic Disorders
   Birgit Waltenberger et al, 2016, Molecules CrossRef
3. Astragaloside IV inhibits isoprenaline-induced cardiac fibrosis by targeting the reactive oxygen species/mitogen-activated protein kinase signaling axis
   Hongliang Dai et al, 2017 CrossRef
4. Melatonin, mitochondria and hypertension
   Ovidiu C. Baltatu et al, 2017, Cell. Mol. Life Sci. CrossRef
5. Improved bioautographic assay on TLC layers for qualitative and quantitative estimation of xanthine oxidase inhibitors and superoxide scavengers
   Yao Kong et al, 2017, Journal of Pharmaceutical and Biomedical Analysis CrossRef
6. Astragaloside IV protects against apoptosis in human degenerative chondrocytes through autophagy activation.
   Jianhong Liu et al, 2017, Mol Med Rep CrossRef
7. Herbal Medications in Cardiovascular Medicine
   Rosa Liperoti et al, 2017, Journal of the American College of Cardiology CrossRef
8. Astragaloside IV inhibits Angiotensin II-stimulated proliferation of rat vascular smooth muscle cells via the regulation of CDK2 activity
   Deng-qing Zhang et al, 2018, Life Sciences CrossRef
9. The Extracts and Major Compounds Derived from Astragali Radix Alter Mitochondrial Bioenergetics in Cultured Cardiomyocytes: Comparison of Various Polar Solvents and Compounds
   Yun Huang et al, 2018, IJMS CrossRef
10. LCZ696 improves cardiac function via alleviating Drp1-mediated mitochondrial dysfunction in mice with doxorubicin-induced dilated cardiomyopathy
    Yan Xia et al, 2017, Journal of Molecular and Cellular Cardiology CrossRef
11. Astragaloside exerts anti-photoaging effects in UVB-induced premature senescence of rat dermal fibroblasts through enhanced autophagy
    Weijie Wen et al, 2018, Archives of Biochemistry and Biophysics CrossRef
12. Astragaloside IV reduces neuronal apoptosis and parthanatos in ischemic injury by preserving mitochondrial hexokinase-II
    Ying Li et al, 2018, Free Radical Biology and Medicine CrossRef
13. Jian-Pi-Yi-Shen Formula ameliorates chronic kidney disease: involvement of mitochondrial quality control network
    Xinhui Liu et al, 2018, BMC Complement Altern Med CrossRef
14. Caloric Restriction Exacerbates Angiotensin II–Induced Abdominal Aortic Aneurysm in the Absence of p53
    Peng Gao et al, 2019, Hypertension CrossRef
15. Astragaloside IV Protects Primary Cerebral Cortical Neurons from Oxygen and Glucose Deprivation/Reoxygenation by Activating the PKA/CREB Pathway
    Bingjie Xue et al, 2019, Neuroscience CrossRef
16. Astragaloside IV protects against cisplatin-induced liver and kidney injury via autophagy-mediated inhibition of NLRP3 in rats
    Xiaoyu Qu et al, 2019, J. Toxicol. Sci. CrossRef
17. The effects of Astragalus Membranaceus Active Extracts on Autophagy-related Diseases
    null Shan et al, 2019, IJMS CrossRef
18. Danggui Buxue Tang, a Chinese Herbal Decoction Containing Astragali Radix and Angelicae Sinensis Radix, Modulates Mitochondrial Bioenergetics in Cultured Cardiomyoblasts
    Kenneth K.L. Kwan et al, 2019, Front. Pharmacol. CrossRef
19. Angiotensin II-Induced Apoptosis of Human Umbilical Vein Endothelial Cells was Inhibited by Blueberry Anthocyanin Through Bax- and Caspase 3-Dependent Pathways.
    Jian Du et al, 0 CrossRef
20. Afzelin ameliorates D-galactosamine and lipopolysaccharide-induced fulminant hepatic failure by modulating mitochondrial quality control and dynamics.
    Sang-Bin Lee et al, 0 CrossRef
21. The putative role of autophagy in the pathogenesis of abdominal aortic aneurysms
    Azza Ramadan et al, 2017, Atherosclerosis CrossRef
22. Reinvestigation of Herniaria glabra L. saponins and their biological activity
    Solomiia Kozachok et al, 2020, Phytochemistry CrossRef
23. Exploring a New Natural Treating Agent for Primary Hypertension: Recent Findings and Forthcoming Perspectives
    null Lin et al, 2019, JCM CrossRef
24. Astragaloside IV reverses simvastatin‐induced skeletal muscle injury by activating the AMPK‐PGC‐1α signalling pathway
    Bing Jiang et al, 2019, Phytotherapy Research CrossRef
25. A novel STAT3 inhibitor attenuates angiotensin II-induced abdominal aortic aneurysm progression in mice through modulating vascular inflammation and autophagy
    Qi-ying Wu et al, 2020, Cell Death Dis CrossRef
26. Mitophagy in Hypertension-Associated Premature Vascular Aging
    Zachary J Schreckenberger et al, 2020 CrossRef
27. Qiangji Jianli Decoction promotes mitochondrial biogenesis in skeletal muscle of myasthenia gravis rats via AMPK/PGC-1α signaling pathway
    Wei Jiao et al, 2020, Biomedicine & Pharmacotherapy CrossRef
28. Investigating the Vascular Toxicity Outcomes of the Irreversible Proteasome Inhibitor Carfilzomib
    Panagiotis Efentakis et al, 2020, IJMS CrossRef
29. Astragaloside IV Extends Lifespan of Caenorhabditis elegans by Improving Age-Related Functional Declines and Triggering Antioxidant Responses
    Jianqin Zhang et al, 2020, Rejuvenation Research CrossRef
30. Natural Drugs as a Treatment Strategy for Cardiovascular Disease through the Regulation of Oxidative Stress
    Xing Chang et al, 2020, Oxidative Medicine and Cellular Longevity CrossRef
31. Vascular Stress Signaling in Hypertension
    Stephanie M. Cicalese et al, 2021, Circ Res CrossRef
32. The implications of mitochondria in doxorubicin treatment of cancer in the context of traditional and modern medicine
    Leonardo da Cunha Menezes Souza et al, 2020, Tradit. Med. Mod. Med. CrossRef
33. IKKε knockout alleviates angiotensin II‑induced apoptosis and excessive autophagy in vascular smooth muscle cells by regulating the ERK1/2 pathway
    Ganyi Chen et al, 2021, Exp Ther Med CrossRef
34. Yiqi Huoxue preserves heart function by upregulating the Sigma‑1 receptor in rats with myocardial infarction
    Lixia Lou et al, 2021, Exp Ther Med CrossRef
35. Molecular Mechanism of Astragaloside IV in Improving Endothelial Dysfunction of Cardiovascular Diseases Mediated by Oxidative Stress.
    Peipei Meng et al, 2021, Oxid Med Cell Longev CrossRef
36. Astragaloside IV Protects Detrusor from Partial Bladder Outlet Obstruction-Induced Oxidative Stress by Activating Mitophagy through AMPK-ULK1 Pathway
    Xiaoyu Zhu et al, 2022, Oxidative Medicine and Cellular Longevity CrossRef
37. Review of the pharmacological effects of astragaloside IV and its autophagic mechanism in association with inflammation.
    Ying Yang et al, 2022, World J Clin Cases CrossRef
38. New insights into vascular aging: Emerging role of mitochondria function
    Yu-juan Li et al, 2022, Biomedicine & Pharmacotherapy CrossRef
39. PINK1/Parkin pathway-mediated mitophagy by AS-IV to explore the molecular mechanism of muscle cell damage
    Lanqi Li et al, 2023, Biomedicine & Pharmacotherapy CrossRef
40. Review on the protective mechanism of astragaloside IV against cardiovascular diseases
    Chunkun Yang et al, 2023, Front. Pharmacol. CrossRef
41. Mitophagy in atherosclerosis: from mechanism to therapy
    Yanhong Zhang et al, 2023, Front. Immunol. CrossRef
42. Natural compounds targeting mitochondrial dysfunction: emerging therapeutics for target organ damage in hypertension
    Xiaolin Liao et al, 2023, Front. Pharmacol. CrossRef
43. Qiliqiangxin: A multifaceted holistic treatment for heart failure or a pharmacological probe for the identification of cardioprotective mechanisms?
    Milton Packer, 2023, European J of Heart Fail CrossRef
44. Mitophagy in hypertension-mediated organ damage
    Yulong Ma et al, 2024, Front. Cardiovasc. Med. CrossRef
45. Astragaloside IV Protects against Shear Stress-Induced Glycocalyx Damage and Alleviates Abdominal Aortic Aneurysm by Regulating miR-17-3p/Syndecan-1
    Guojian Li et al, 2024, Analytical Cellular Pathology CrossRef
46. Angiotensin II Alters Mitochondrial Membrane Potential and Lipid Metabolism in Rat Colonic Epithelial Cells
    Darby D. Toth et al, 2024, Biomolecules CrossRef
47. A new strategy for Astragaloside IV in the treatment of diabetic kidney disease: Analyzing the regulation of ferroptosis and mitochondrial function of renal tubular epithelial cells
    Jun Liu et al, 2024, International Immunopharmacology CrossRef
48. SUV39H1 Inhibits Angiogenesis in Limb Ischemia of Mice
    Wenhao Niu et al, 2023, Cell Transplant CrossRef
49. The impact of X-rays on cardiac hydrometabolism and the regulatory role of AS-IV
    Zhang Shangzu et al, 2024, International Immunopharmacology CrossRef
50. Naotaifang formula regulates Drp1-induced remodeling of mitochondrial dynamics following cerebral ischemia-reperfusion injury
    Ruining She et al, 2025, Free Radical Biology and Medicine CrossRef